Vaccine shown to be cost-effective and trusted by caregivers and health care workers
PATH's Malaria Vaccine Initiative
Accelerating Malaria Vaccine Development
PATH welcomes landmark financing agreement for GSK's malaria vaccine
PATH congratulates Gavi, GSK, and MedAccess for joining forces to help ensure an ongoing supply of the first malaria vaccine, RTS,S/AS01E.
PATH welcomes US$ 5 million grant to expand malaria vaccine access in Ghana, Kenya, and Malawi
Funding from Open Philanthropy Foundation will expand access to RTS,S/AS01 in pilot areas of Ghana, Kenya, and Malawi...
PATH welcomes commitment by Gavi board to finance wider rollout of the world’s first malaria vaccine, RTS,S
Together with partners and other stakeholders, PATH is working to help ensure sufficient malaria vaccine supply to meet potential demand.
Home
-
Need for vaccines
A vaccine could help to close the gap left by other malaria control interventions. -
Malaria vaccine roadmap
The roadmap outlines a path for accelerating the development of malaria vaccines. -
RTS,S
RTS,S is the first malaria vaccine recommended for broad use by WHO. -
Next-generation vaccines
The next generation of malaria vaccines would aim to reduce transmission of the parasite.